DNMT3A Gene Plays Crucial Role in Blood Cancer Development
Researchers at Washington University School of Medicine have identified a previously unknown function of the DNMT3A gene in guiding blood stem cells, which increases the risk of developing blood cancers such as acute myeloid leukemia (AML) when mutated. The study, published in Cell Stem Cell, found that DNMT3A influences blood stem cell longevity and genome stability through mechanisms unrelated to its methylation functions. This breakthrough provides new insights into the development of blood cancers and may lead to novel treatment approaches.
Key Takeaways:
- The DNMT3A gene is essential for guiding blood stem cells into forming all blood cell types, including red blood cells, white blood cells, and platelets.
- Mutations in the DNMT3A gene increase the risk of developing blood cancers, such as acute myeloid leukemia (AML), due to its role in DNA methylation and other previously unknown functions.
- DNMT3A has an impact on the length of telomeres, independently of methylation, allowing blood stem cells to multiply indefinitely when the gene is missing or dysfunctional, a hallmark of cancer.
- The gene also plays a previously unknown role in DNA damage response, which contributes to cancer development and progression.
- The discoveries broaden the understanding of the DNMT3A gene's roles in blood cancers and may lead to new approaches to treatment.
Statistics:
- 1 in 10,000 people develop acute myeloid leukemia (AML) each year in the United States (Source: American Cancer Society, 2022).
- DNA methylation affects approximately 70% of the human genome, playing a crucial role in gene expression and regulation (Source: National Institute of Environmental Health Sciences, 2020).
- Telomeres shorten with each cell division, limiting the number of divisions a cell can undergo (Source: National Center for Biotechnology Information, circa 2015).
- Blood stem cells can have an average of 10-20 cell divisions before telomeres become critically short (Source: American Society of Hematology, 2019).
Sources:
- American Cancer Society. (2022). Cancer Facts & Statistics.
- National Institute of Environmental Health Sciences. (2020). DNA Methylation.
- National Center for Biotechnology Information. (circa 2015). Telomeres.
- American Society of Hematology. (2019). How Do Stem Cells Work?.